Clinical Trial Update: Capecitabine In Combination With Cemiplimab In Patient With Metastatic Breast Cancer [Phase 1]

View source ↗

Summary

A completed Phase 1 trial evaluated the combination of capecitabine and cemiplimab in patients with metastatic breast cancer, including hormone receptor-positiv…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Hormone Receptor-positive Breast Cancer

Drugs mentioned

• Libtayo (cemiplimab)
• Xeloda (capecitabine)

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Hormone Receptor-positive Breast Cancer | Phase 1 | Status: COMPLETED